These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24018436)

  • 1. [New cytochrome P450 isoforms as cancer biomarkers and targets for chemopreventive and chemotherapeutic agents].
    Szaefer H; Cichocki M; Majchrzak-Celińska A
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():709-18. PubMed ID: 24018436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1.
    Wu ZL; Sohl CD; Shimada T; Guengerich FP
    Mol Pharmacol; 2006 Jun; 69(6):2007-14. PubMed ID: 16551781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of human cytochrome P450s: characterization of the orphans.
    Guengerich FP; Wu ZL; Bartleson CJ
    Biochem Biophys Res Commun; 2005 Dec; 338(1):465-9. PubMed ID: 16126164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenobiotic metabolising enzyme expression in colonic neoplasia.
    McKay JA; Murray GI; Weaver RJ; Ewen SW; Melvin WT; Burke MD
    Gut; 1993 Sep; 34(9):1234-9. PubMed ID: 8406161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.
    Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI
    Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of orphan human cytochromes P450.
    Stark K; Guengerich FP
    Drug Metab Rev; 2007; 39(2-3):627-37. PubMed ID: 17786643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal CYP2 family cytochromes P450.
    Du L; Hoffman SM; Keeney DS
    Toxicol Appl Pharmacol; 2004 Mar; 195(3):278-87. PubMed ID: 15020190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions.
    Rooney PH; Telfer C; McFadyen MC; Melvin WT; Murray GI
    Curr Cancer Drug Targets; 2004 May; 4(3):257-65. PubMed ID: 15134533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone.
    Jugert FK; Agarwal R; Kuhn A; Bickers DR; Merk HF; Mukhtar H
    J Invest Dermatol; 1994 Jun; 102(6):970-5. PubMed ID: 8006463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450-based cancer gene therapy: recent advances and future prospects.
    Waxman DJ; Chen L; Hecht JE; Jounaidi Y
    Drug Metab Rev; 1999 May; 31(2):503-22. PubMed ID: 10335450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.
    Chen L; Waxman DJ
    Curr Pharm Des; 2002; 8(15):1405-16. PubMed ID: 12052216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific expression of cytochrome P450 CYP1B1.
    Murray GI; Taylor MC; McFadyen MC; McKay JA; Greenlee WF; Burke MD; Melvin WT
    Cancer Res; 1997 Jul; 57(14):3026-31. PubMed ID: 9230218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
    Roy P; Waxman DJ
    Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.
    Kumarakulasingham M; Rooney PH; Dundas SR; Telfer C; Melvin WT; Curran S; Murray GI
    Clin Cancer Res; 2005 May; 11(10):3758-65. PubMed ID: 15897573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced bacterial expression of several mammalian cytochrome P450s by codon optimization and chaperone coexpression.
    Wu ZL; Qiao J; Zhang ZG; Guengerich FP; Liu Y; Pei XQ
    Biotechnol Lett; 2009 Oct; 31(10):1589-93. PubMed ID: 19557307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway.
    Chiaro CR; Patel RD; Marcus CB; Perdew GH
    Mol Pharmacol; 2007 Nov; 72(5):1369-79. PubMed ID: 17720764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytochrome P450 in tumour development and progression and its potential in therapy.
    Murray GI
    J Pathol; 2000 Dec; 192(4):419-26. PubMed ID: 11113857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human cytochromes P450. Applications in pharmacology].
    Beaune P
    Therapie; 1993; 48(6):521-6. PubMed ID: 8091338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of cytochrome p450 in brain drug metabolism.
    Meyer RP; Gehlhaus M; Knoth R; Volk B
    Curr Drug Metab; 2007 May; 8(4):297-306. PubMed ID: 17504219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.